Earnings Reportpositive

Earnings Report

Other upcoming events for OPK

Phase 2 StartPhase 2 Start: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of OPK-88006 in Healthy and Presumed
Patent ExpiryPatent/Exclusivity Expiry: RAYALDEE

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Earnings Report — OPK Earnings Report | BioSniper